Pharmafile Logo

Gower Publishing

- PMLiVE

US charges Teva for generic drug price-fixing plot

Company maintains it has not committed any wrongdoing

Sanofi reception

Translate Bio, Sanofi’s COVID-19 vaccine proves promising in animal studies

Vaccine was able to induce neutralising antibodies and T-cell responses

- PMLiVE

Novartis’ asciminib tops Pfizer’s Bosulif in chronic myeloid leukaemia trial

Drug improved major molecular response compared to existing med

- PMLiVE

A day in the life of the Global Head of Publications

We asked Mina Patel to give us an insight into her role as Global Head of Publications at OPEN Health

OPEN Health

- PMLiVE

Takeda to sell Japan consumer health unit for $2.3bn

Deal helps to reduce debt accrued from Shire takeover

- PMLiVE

EU concludes discussions with Moderna for COVID-19 vaccine

Biotech company on the verge on finalising supply deal

- PMLiVE

WHO says 172 countries are poised to participate in COVID-19 vaccine initiative

Countries have until 31 August to submit an expression of interest in joining the initiative

- PMLiVE

Novavax begins phase 2 portion of COVID-19 vaccine trial

Trial will enrol up to 1,500 participants in the US and Australia

Consumer health specialist joins Research Partnership Inc

Global healthcare market research consultancy Research Partnership has appointed Jennifer Stewart as a Director in their US offices in Philadelphia.

Inizio

White paper helps industry navigate new NHS roadmap

New report shows how pharma can support the NHS in the Covid-19 recovery era

Wilmington Healthcare

- PMLiVE

COVID-19 vaccine ‘unlikely’ to be available this year, says UK’s chief medical officer

Chris Whitty warns that there is no certainty that an effective vaccine will be available before winter 2021

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links